Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature

References

• Jennette, J.C., Falk, R.J. Small-vessel vasculitis. N. Engl. J. Med. 1997, 337, 1512–1523.
   PubMed Web of Science ®Google Scholar
• Carlson, J.A., Cavaliere, L.F., Grant-Kels, J.M. Cutaneous vasculitis: diagnosis and management. Clin. Dermatol. 2006, 24, 414–429.
   PubMed Web of Science ®Google Scholar
• Choi, H.K., Merkel, P.A., Walker, A.M., Niles, J.L. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43, 405–413.
   PubMed Web of Science ®Google Scholar
• Savige, J., Davies, D., Falk, R.J., Jennette, J.C., Wiik, A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000, 57, 846–862.
   PubMed Web of Science ®Google Scholar
• Cooper, D.S. Antithyroid drugs. N. Engl. J. Med. 2005, 352, 905–917.
   PubMed Web of Science ®Google Scholar
• Ye, Y.M., Kim, J.E., Kim, J.H., Choi, G.S., Park, H.S. Propylthiouracil-induced DRESS syndrome confirmed by a positive patch test. Allergy 2010, 65, 407–409.
   PubMed Web of Science ®Google Scholar
• Seo, J.W., Son, H.H., Choi, J.H., Lee, S.K. A case of p-ANCA-positive propylthiouracil-induced pyoderma gangrenosum. Ann. Dermatol. 2010, 22, 48–50.
   PubMed Web of Science ®Google Scholar
• Stankus, S.J., Johnson, N.T. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992, 102, 1595–1596.
   PubMed Web of Science ®Google Scholar
• Dolman, K.M., Gans, R.O., Vervaat, T.J., Zevenbergen, G., Maingay, D., Nikkels, R.E., Donker, A.J., von dem Borne, A.E., Goldschmeding, R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993, 342, 651–652.
   PubMed Web of Science ®Google Scholar
• Hachicha, M., Kammoun, T., Ben Romdhane, W., Ben Abdallah, R., Mahfoudh, A., Kammoun, K., Hachicha, J., Triki, A. [Vasculitis with renal involvement and antineutrophil cytoplasmic antibodies (ANCA) in a child receiving benzylthiouracil]. Nephrol. Ther. 2007, 3, 147–151.
   PubMed Web of Science ®Google Scholar
• Barbaud, A., Gonçalo, M., Bruynzeel, D., Bircher, A.; European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm. 2001, 45, 321–328.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D.S., Fregert, S., Magnusson, B., Bandmann, H.J., Calnan, C.D., Cronin, E., Hjorth, N., Maibach, H.J., Malalten, K.E., Meneghini, C.L., Pirilä, V. Terminology of contact dermatitis. Acta Derm. Venereol. 1970, 50, 287–292.
   PubMed Web of Science ®Google Scholar
• Noh, J.Y., Asari, T., Hamada, N., Makino, F., Ishikawa, N., Abe, Y., Ito, K., Ito, K. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves’ disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin. Endocrinol. (Oxf) 2001, 54, 651–654.
   PubMed Web of Science ®Google Scholar
• Sato, H., Hattori, M., Fujieda, M., Sugihara, S., Inomata, H., Hoshi, M., Miyamoto, S. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 2000, 85, 4270–4273.
   PubMed Web of Science ®Google Scholar
• Yazisiz, V., Ongüt, G., Terzioglu, E., Karayalçin, U. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int. J. Clin. Pract. 2010, 64, 19–24.
   PubMed Web of Science ®Google Scholar
• von Schmiedeberg, S., Goebel, C., Gleichmann, E., Uetrecht, J. Neutrophils and drug metabolism. Science 1995, 268, 585–586.
   PubMed Web of Science ®Google Scholar
• Jiang, X., Khursigara, G., Rubin, R.L. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994, 266, 810–813.
   PubMed Web of Science ®Google Scholar
• Cambridge, G., Wallace, H., Bernstein, R.M., Leaker, B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 1994, 33, 109–114.
   PubMedGoogle Scholar
• Lee, E., Miki, Y., Katsura, H., Kariya, K. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem. Pharmacol. 1990, 39, 1467–1471.
   PubMed Web of Science ®Google Scholar
• Yu, F., Zhao, M.H., Zhang, Y.K., Zhang, Y., Wang, H.Y. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin. Exp. Immunol. 2005, 139, 569–574.
   PubMed Web of Science ®Google Scholar
• Ye, H., Gao, Y., Guo, X.H., Zhao, M.H. Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin. Exp. Immunol. 2005, 142, 116–119.
   PubMed Web of Science ®Google Scholar
• Gao, Y., Chen, M., Ye, H., Guo, X.H., Zhao, M.H., Wang, H.Y. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin. Endocrinol. (Oxf) 2007, 66, 543–547.
   PubMed Web of Science ®Google Scholar
• Gao, Y., Chen, M., Ye, H., Yu, F., Guo, X.H., Zhao, M.H. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford). 2008, 47, 1515–1520.
   PubMed Web of Science ®Google Scholar
• Gunton, J.E., Stiel, J., Caterson, R.J., McElduff, A. Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J. Clin. Endocrinol. Metab. 1999, 84, 13–16.
   PubMed Web of Science ®Google Scholar
• Gao, Y., Zhao, M.H., Guo, X.H., Xin, G., Gao, Y., Wang, H.Y. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr. Res. 2004, 30, 205–213.
   PubMed Web of Science ®Google Scholar
• Lionaki, S., Hogan, S.L., Falk, R.J., Joy, M.S., Chin, H., Jennette, C.E., Jennette, J.C., Nachman, P.H. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case–control study. Nephrol. Dial. Transplant. 2007, 22, 3508–3515.
   PubMed Web of Science ®Google Scholar
• Batchelor, N., Holley, A. A fatal case of propylthiouracil-induced ANCA-positive vasculitis. MedGenMed 2006, 8, 10.
   PubMedGoogle Scholar
• Stein, J.C., Hernandez, S., Hebig, A. Necrotizing vasculitis as a complication of propylthiouracil. West. J. Emerg. Med. 2008, 9, 212–215.
   PubMedGoogle Scholar
• Chen, Y.X., Yu, H.J., Ni, L.Y., Zhang, W., Xu, Y.W., Ren, H., Chen, X.N., Wang, X.L., Li, X., Pan, X.X., Wang, W.M., Chen, N. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J. Rheumatol. 2007, 34, 2451–2456.
   PubMed Web of Science ®Google Scholar
• Jennette, J.C., Xiao, H., Falk, R.J. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J. Am. Soc. Nephrol. 2006, 17, 1235–1242.
   PubMed Web of Science ®Google Scholar
• Gao, Y., Chen, M., Ye, H., Guo, X.H., Zhao, M.H., Wang, H.Y. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int. Immunopharmacol. 2007, 7, 55–60.
   PubMed Web of Science ®Google Scholar
• Bonaci-Nikolic, B., Nikolic, M.M., Andrejevic, S., Zoric, S., Bukilica, M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 2005, 7, R1072–R1081.
   PubMed Web of Science ®Google Scholar
• ten Holder, S.M., Joy, M.S., Falk, R.J. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. 2002, 36, 130–147.
   PubMed Web of Science ®Google Scholar
• Noh, J.Y., Yasuda, S., Sato, S., Matsumoto, M., Kunii, Y., Noguchi, Y., Mukasa, K., Ito, K., Ito, K., Sugiyama, O., Kobayashi, H., Nihojima, S., Okazaki, M., Yokoyama, S. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab. 2009, 94, 2806–2811.
   PubMed Web of Science ®Google Scholar
• Fujieda, M., Hattori, M., Kurayama, H., Koitabashi, Y. Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol. 2002, 13, 437–445.
   PubMed Web of Science ®Google Scholar
• Quax, R.A., Swaak, A.J., Baggen, M.G. Churg–Strauss syndrome following PTU treatment. Int. J. Rheumatol. 2009, 2009, 504105.
   PubMedGoogle Scholar
• Zhao, M.H., Chen, M., Gao, Y., Wang, H.Y. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2006, 69, 1477–1481.
   PubMed Web of Science ®Google Scholar
• Hogan, S.L., Falk, R.J., Chin, H., Cai, J., Jennette, C.E., Jennette, J.C., Nachman, P.H. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann. Intern. Med. 2005, 143, 621–631.
   PubMed Web of Science ®Google Scholar
• Ishii, R., Imaizumi, M., Ide, A., Sera, N., Ueki, I., Horie, I., Ando, T., Usa, T., Ejima, E., Ashizawa, K., Eguchi, K. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil. Endocr. J. 2010, 57, 73–79.
   PubMed Web of Science ®Google Scholar
• Gao, Y., Ye, H., Yu, F., Guo, X.H., Zhao, M.H. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin. Immunol. 2005, 117, 87–93.
   PubMed Web of Science ®Google Scholar
• Ahmed, K., Rao, S., Simha, V. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. Endocr. Pract. 2010, 16, 449–451.
   PubMed Web of Science ®Google Scholar
• Peters, H., Fischer, C., Bogner, U., Reiners, C., Schleusener, H. Treatment of Graves’ hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997, 7, 247–251.
   PubMed Web of Science ®Google Scholar
• Stone, O.J. Proliferative iododerma. A possible mechanism. Int. J. Dermatol. 1985, 24, 565–566.
   PubMed Web of Science ®Google Scholar